Terms: = Lung cancer AND MTCP1, C6_1B, 4515, ENSG00000214827, GS1-273L24_4 AND Clinical Outcome
715 results:
1. clinical and Imaging Characteristics of SARS-CoV-2 Breakthrough Infection in Hospitalized Immunocompromised Patients.
Lee JE; Kim J; Hwang M; Kim YH; Chung MJ; Jeong WG; Jeong YJ
Korean J Radiol; 2024 May; 25(5):481-492. PubMed ID: 38627873
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic impact of age in advanced non-small cell lung cancer patients undergoing first-line checkpoint inhibitor immunotherapy and chemotherapy treatment.
Huang X; Wu S; Chen S; Qiu M; Zhao Y; Wei J; He J; Zhao W; Tan L; Su C; Zhou S
Int Immunopharmacol; 2024 May; 132():111901. PubMed ID: 38554448
[TBL] [Abstract] [Full Text] [Related]
3. Spreading Through Air Spaces And Thinking About lung Metastases.
M Castro P; Rei J; Silva C; Miranda J; Guerra M
Port J Card Thorac Vasc Surg; 2023 Oct; 30(3):31-35. PubMed ID: 38499034
[TBL] [Abstract] [Full Text] [Related]
4. Kinome-Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma.
Vella V; Ditsiou A; Chalari A; Eravci M; Wooller SK; Gagliano T; Bani C; Kerschbamer E; Karakostas C; Xu B; Zhang Y; Pearl FMG; Lopez G; Peng L; Stebbing J; Klinakis A; Giamas G
Adv Sci (Weinh); 2024 Apr; 11(15):e2306027. PubMed ID: 38353396
[TBL] [Abstract] [Full Text] [Related]
5. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
[TBL] [Abstract] [Full Text] [Related]
6. Sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype.
Chang HY; Dermawan J; Sharma A; Dickson B; Turashvili G; Torrence D; Nucci M; Chiang S; Oliva E; Kirchner M; Stenzinger A; Mechtersheimer G; Antonescu C
Mod Pathol; 2024 Feb; 37(2):100402. PubMed ID: 38141829
[TBL] [Abstract] [Full Text] [Related]
7. Circulating Immune Proteins: Improving the Diagnosis and clinical outcome in Advanced Non-Small Cell lung cancer.
Torres-Martínez S; Calabuig-Fariñas S; Gallach S; Mosqueda M; Munera-Maravilla E; Sirera R; Navarro L; Blasco A; Camps C; Jantus-Lewintre E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139416
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective.
Aggarwal A; Sharma S; Brar Z; Kumar V; Kumar A; Katara R; Mohanty SK
Pathol Res Pract; 2024 Jan; 253():155013. PubMed ID: 38096714
[TBL] [Abstract] [Full Text] [Related]
9. [Comparison of Quality of Life of the Patients Three Months after Uniportal
and Multiportal Thoracoscopic Lobectomy].
Zhang Q; Dai W; Wei X; Xiang R; Gu H; Hu P; Liu M; Chen W; Gong H; Liang Y; Zhang S; Peng W; Shi Q; Li Q; Yu N
Zhongguo Fei Ai Za Zhi; 2023 Nov; 26(11):843-850. PubMed ID: 38061886
[TBL] [Abstract] [Full Text] [Related]
10. Poor Efficacy of Immune Checkpoint Inhibitors Plus Chemotherapy in lung cancer Patients with EGFR/ERBB2 Exon 20 Insertion.
Zheng Y; Fu Y; Chen Y; Li Q; Liu T; Ding Z
Curr Oncol; 2023 Nov; 30(11):9929-9939. PubMed ID: 37999141
[TBL] [Abstract] [Full Text] [Related]
11. Investigating the prognostic value of constructing disulfidptosis-related gene models for lung adenocarcinoma patients.
Luo M; Liu RZ; Li YJ; Zhang SD; Wu ZY
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9569-9585. PubMed ID: 37916324
[TBL] [Abstract] [Full Text] [Related]
12. Immune Features of Tumor Microenvironment: A Genetic Spotlight.
Asadi M; Zarredar H; Zafari V; Soleimani Z; Saeedi H; Caner A; Shanehbandi D
Cell Biochem Biophys; 2024 Mar; 82(1):107-118. PubMed ID: 37870699
[TBL] [Abstract] [Full Text] [Related]
13. Co-Occurring Alterations in Multiple Tumor Suppressor Genes Are Associated With Worse outcomes in Patients With EGFR-Mutant lung cancer.
Stockhammer P; Grant M; Wurtz A; Foggetti G; Expósito F; Gu J; Zhao H; Choi J; Chung S; Li F; Walther Z; Dietz J; Duffield E; Gettinger S; Politi K; Goldberg SB
J Thorac Oncol; 2024 Feb; 19(2):240-251. PubMed ID: 37806385
[TBL] [Abstract] [Full Text] [Related]
14. Thyroid transcription factor-1 expression in lung neuroendocrine tumours: a gender-related biomarker?
La Salvia A; Siciliani A; Rinzivillo M; Verrico M; Baldelli R; Puliani G; Modica R; Zanata I; Persano I; Fanciulli G; Bassi M; Mancini M; Bellino S; Giannetta E; Ibrahim M; Panzuto F; Brizzi MP; Faggiano A
Endocrine; 2024 Feb; 83(2):519-526. PubMed ID: 37775725
[TBL] [Abstract] [Full Text] [Related]
15. Integrated analysis of phase 1a and 1b randomized controlled trials; Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors.
Fujikawa K; Saito T; Kurose K; Kojima T; Funakoshi T; Sato E; Kakimi K; Iida S; Doki Y; Oka M; Ueda R; Wada H
PLoS One; 2023; 18(9):e0291772. PubMed ID: 37729184
[TBL] [Abstract] [Full Text] [Related]
16. Primary lung adenocarcinoma mimicking recurrent pneumonia in a young adult.
Joshi T; Rahman Y; Yeung HM
BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37597859
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy of Tyrosine Kinase Inhibitors in Primary Driver-Gene-Positive Combined Small-Cell lung cancer: A Retrospective Study.
Shi Z; Wei J; Sun W; Zeng X; Zhou H; Song Z
Clin Lung Cancer; 2023 Dec; 24(8):717-725.e1. PubMed ID: 37482500
[TBL] [Abstract] [Full Text] [Related]
18. Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study.
Nicholson BD; Oke J; Virdee PS; Harris DA; O'Doherty C; Park JE; Hamady Z; Sehgal V; Millar A; Medley L; Tonner S; Vargova M; Engonidou L; Riahi K; Luan Y; Hiom S; Kumar H; Nandani H; Kurtzman KN; Yu LM; Freestone C; Pearson S; Hobbs FR; Perera R; Middleton MR
Lancet Oncol; 2023 Jul; 24(7):733-743. PubMed ID: 37352875
[TBL] [Abstract] [Full Text] [Related]
19. Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer.
Benzaquen J; Bondiau PY; Otto J; Marquette CH; Berthet JP; Naghavi AO; Schiappa R; Hannoun-Levi JM; Padovani B; Doyen J
Radiat Oncol; 2023 Jun; 18(1):97. PubMed ID: 37287020
[TBL] [Abstract] [Full Text] [Related]
20. Association of
Singh S; Singh N; Baranwal M; Sharma S
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147951
[TBL] [Abstract] [Full Text] [Related]
[Next]
